CDISC Data Standards Validation
|
|
- Nora Henderson
- 6 years ago
- Views:
Transcription
1 CDISC Data Standards Validation How can it be done? Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel Fax Mobile peter.vanreusel@businessdecision.com Sint-Lambertusstraat 141 Rue Saint- Lambert 1200 Brussels
2 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary
3 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary
4 FDA Submissions (1) It is requested to submit clinical trial data (SDTM) & metadata (Define.xml) according to the SDTMIG V3.1.2 standards It is highly recommended to submit analysis data (ADaM) and metadata (Define.xml) according to the ADaMIG V1.0 standards Data standards allow the FDA to use standard tools
5 FDA Submissions (2) Applies to both FDA CBER and FDA CDER (Study Data Specifications) nrequirements/electronicsubmissions/ucm pdf CBER has recently released new documentation for submitting data to CBER (Submision of data in CDISC format to CBER) Office of Vaccines Research and Review May 15, 2010 Office of Blood Research and Review September 1, 2010 Office of Cellular and Gene Therapies December htm CDER has prepared a Data Standards Plan which will be released to the public soon nrequirements/electronicsubmissions/ucm pdf
6 SDTM FDA Tools: Patient Profile Viewer
7 SDTM FDA Tools: JReview (1)
8 SDTM FDA Tools: JReview (2) v3.1 Training Materials
9 SDTM FDA Tools: WebSDM (1) v3.1 Training Materials
10 SDTM FDA Tools: WebSDM (2)
11 SDTM FDA Tools: WebSDM (3)
12 CDISC Data Model Conformance (SDTM & ADaM) Follow complete metadata structure Follow CDISC domain models Include all Required and Expected variables Use CDISC-specified: standard domain names and prefixes standard variable names variable labels (SDTM only) data types for all variables (SDTM only) controlled terminology and format guidelines Currently, adhere to the SAS V5 XPT limitations Ensure that each dataset includes a set of keys Ensure that each record in a dataset includes a topic variable (SDTM only) Conform to all business rules
13 Results of non-compliance Not following data standards will: break the tools create confusion and frustration give the impression that the sponsor does not control the data
14 Current status (1) Validation check history WebSDM (1.5, 2.6, 3.0), SDTMIG (3.1, 3.1.1, 3.1.2), ADaMIG (1.0) Today, different vendors have developed a specific tool WebSDM Data Model Compliance Checker Validator Checkpoint Clinical Standards Toolkit
15 Current status (2) Different vendors have created different checks Different tools are producing different output Rules and checks are not clearly defined There is no official version yet
16 Current status (3) ADaM team: Has published ADaMIG V1.0 ( Dec. 17, 2009) Has developed a draft check list (June 11, 2010) Is preparing a final version SDTM team did not create a check list CDISC has started the CAB VP CDISC Advisory Board Validation Project To create one official version of the SDTM checks Broad industry representation Representing all of the 5 major vendors and the FDA
17 Current status (4) Ongoing comparison and consolidation between all checks Unambiguous check specification will avoid check interpretation
18 FDA CRT Submission Process (1) Data Tabulation Components: SDTM annotated CRFs SDTM datasets ADaM datasets Define.xml metadata
19 FDA CRT Submission Process (2) WebSDM and OpenCDISC tools check the CDISC SDTM data & metadata to ensure standard FDA tools can be used
20 FDA CRT Submission Process (3) CDISC SDTM (& ADaM) compliance issues are reported to the sponsor
21 Janus layers Source: «CDISC Standards, Present & Future», Dave Iberson-Hurst, CDISC, VP Technical Strategy
22 SDTM Compliance Issues Report OBPS provides an SDTM issue list to the sponsor OBPS = Office of Business Process Support Loading issues can be caused by Data & Metadata Inconsistency Non conformity with:» SDTM Model» SDTM IG business rules» Controlled Terminology
23 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary
24 CDISC Compliance Checks We have created an expanded & enhanced list of checks 154 WebSDM checks Total check package: SDTMIG V3.1.1 SDTMIG V3.1.2 ADaMIG V1.0 Data checks Metadata checks Mapping checks Project consistency checks CDISC compliance checks list is growing continuously
25 Categorization CDISC Compliance Checks Categories Data Metadata Class Domain Mapping Timing variables Data model version Check version
26 Application Flowchart Metadata definition of the data model or sponsor proprietary data standards + CDISC controlled terminology
27 Application Flowchart The data model compliance checks system reads the folder with the SDTM, ADaM datasets & the define.xml metadata file
28 Application Flowchart DEFINE.XML SDTM DATASETS ADaM DATASETS DATA & METADATA ENVIRONMENT METADATA DATABASE CHECK SCHEDULER EXCEPTION TABLE SDTMIG V3.1.1 SDTMIG V3.1.2 ADaMIG V1.0 METADATA LIBRARY Metadata Cross Checks DEFINED JOB CHECK SELECTION SDTM COMPLIANCE ISSUE REPORT Data Model Compliance Checks cross-check for consistency between: CDISC SDTM or ADaM datasets definition Metadata reported in the Define.xml CDISC SDTM, ADaM or sponsor proprietary data standards in the metadata library
29 Application Flowchart A job definition is created in the application interface
30 Application Flowchart Identified quality issues are added to an exception table Quality check reports are generated for further processing
31 Application Interface
32 Application Interface Data Model Selection Screen Select Data Model Possibility to add proprietary data models Select Controlled Terminology CDISC Controlled Terminology Possibility to include sponsor-defined controlled terminology
33 Application Interface
34 Application Interface Job Creation Screen Check Selection : Select Project and Study Select Checks based on Class Events, Interventions, Findings, Trial Design, Special Purpose, Findings About Type Data, Metadata, Programming Individual Select from dynamically created list of domains Creates Job ID Check Description : Detailed description of all checks Possibility of adding/modifying check descriptions
35 Application Interface Check Selection :
36 Application Interface Check Description:
37 Application Interface Run Job Screen Job List :» Lists Job ID, Job description, Job owner, Job creation date» Select the job to run Job Description :» Lists project and studyid for the selected job» Lists checks to run for the selected job» Lists domains on which selected checks run
38 Application Interface Job List
39 Application Interface Job Description
40 Application Interface Parameter Database Central table for project and study parameters
41 Reporting Tool (1) 3 reports are created: Exception log Exception summary Exception report > 50 exceptions per check per domain: only 3 exceptions are reported
42 Reporting Tool (2) 3 reports are created: Exception log Exception summary Exception report > 50 exceptions per check per domain: only 3 exceptions are reported
43 Reporting Tool (3) 3 reports are created: Exception log Exception summary Exception report > 50 exceptions per check per domain: only 3 exceptions are reported Reported Exception Record Identifiers Exception Attributes
44 Topics 1 Current Situation 2 Applied CDISC Compliance 3 Summary
45 Summary CDISC compliance will facilitate: The use of the FDA tools In-house communication between CRO and sponsors Running these checks do not necessarily solve all findings but sponsor is prepared for FDA feedback Document confirmed issues in FDA Reviewers Guide CBER calls this the Validation and Data Interpretation Report FDA will not reject your submission (yet)!
46
47 Thank you for your attention Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel Fax Mobile peter.vanreusel@businessdecision.com Sint-Lambertusstraat 141 Rue Saint- Lambert 1200 Brussels
The Evolution of SDTM
The Evolution of SDTM What s new? Tina Apers CRO Manager Mobile +32 476 60 08 79 tina.apers@businessdecision.com Business & Decision Life Sciences Tel +32 2 774 11 00 Fax +32 2 774 11 99 Sint-Lambertusstraat
More informationStandardize Study Data for Electronic Submission
PharmaSUG China 2018 - Paper CD-43 ABSTRACT Standardize Study Data for Electronic Submission Qin Li, Regeneron Pharmaceuticals Inc. In December 2014, FDA announced that submissions under NDAs, ANDAs, BLAs,
More informationSAS Drug Development in action: efficient standards libraries and study management modules together called CDmation.
SAS Drug Development in action: efficient standards libraries and study management modules together called CDmation. Mark Lambrecht (SAS) Peter Van Reusel (Business & Decision Life Sciences) The clinical
More informationSAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER
SAS SUPPORT CDISC AND CLINICAL METADATA MANAGEMENT BILL GIBSON SAS HLS GLOBAL PRACTICE PRINCIPAL PRODUCT MANAGER OVERVIEW AND INTRODUCTION Abstract: SAS s current and future support of CDISC, such as possible
More informationConformance Rules how to follow and comply when specified by multiple sources?
Conformance Rules 05-Nov-2018 1 Conformance Rules how to follow and comply when specified by multiple sources? PhUSE EU Connect 2018 Francis Dsa Agenda Conformance Rules 05-Nov-2018 2 Different sources
More informationCDISC End-to-End UK User Group Meeting GSK, Stockley Park 24 th October 2007 Dave Iberson-Hurst CDISC VP Technical Strategy CDISC 2007 Dave Iberson-Hurst CDISC VP Technical Strategy Co-lead Technical Advisory
More informationEvolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network
Evolving Regulatory Guidance on Submission of Standardized Data James R. Johnson, PhD RTP CDISC User Network 2014-06-11 Originally Presented at PhUSE Conference 2013 Brussels, Belgium (Paper Number: RG03)
More informationSupporting A Data Review and Visualization Application With SDTM
Paper DV09 Supporting A Data Review and Visualization Application With SDTM Deepika Sunkara, MS, Covance, King of Prussia, Pennsylvania Jagadish Dhanraj, MS, Medimmune, Gaithersburg, Maryland ABSTRACT
More informationOctober, Integration and Implementation of CDISC Standards
Integration and Implementation of CDISC Standards October, 2008 Barbara Lentz, Associate Director, Electronic Data Management Standards, Processes & Training Pat Majcher, Statistical Reporting Services
More informationSDTM and SEND An Integrated View and Approach
SDTM and SEND An Integrated View and Approach PhUSE Connect 2018 Veena Nataraj Cheryl Riel Overview Nonclinical and Clinical Development Phase Regulatory Agency Needs Deliverables to Regulatory Agencies
More informationThe Evolution of SDTM What s new
Paper CD10 The Evolution of SDTM What s new Tina Apers, Business & Decision Life Sciences, Brussels, Belgium ABSTRACT In July 2012 CDISC released the final version of SDTM V1.3 and SDTMIG V3.1.3. This
More informationCDISC Standards: Current and Future
CDISC 2010 CDISC Standards: Current and Future CDISC Japan Interchange Tokyo, Japan 20 July 2010 Rebecca D. Kush, PhD President and CEO, CDISC Clinical Research Standards (Content) (Protocol-driven Research;
More informationClinical Data Standards & Automation
Clinical Data Standards & Automation PhUSE 2007 Author: Giri Balasubramanian Company Name: Kinship Technologies Pvt. Ltd., Table of Contents EXECUTIVE SUMMARY... 3 1.0 INTRODUCTION... 4 2.0 WHY AUTOMATION?...
More informationCDISC Italian UN Aggiornamento/Attività
CDISC Italian UN Aggiornamento/Attività CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda Risposte Questionario Partecipanti CDISC in a
More informationDISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013
DISCOVER DEFINE- XML PRACTICAL USES END-TO-END TODAY Mark Wheeldon CEO Formedix Bay Area User Group May 23, 2013 AGENDA Introduction Your Clinical Trials Automated. Everywhere. Define Driven Dataset Libraries
More informationFrom Standards that Cost to Standards that Save: Cost Effective Standards Implementation
From Standards that Cost to Standards that Save: Cost Effective Standards Implementation Jeffrey M. Abolafia, Rho, Chapel Hill, NC Frank DiIorio, CodeCrafters Inc., Philadelphia, PA Warning This presentation
More informationPharmaSUG Paper IB15
PharmaSUG 2016 - Paper IB15 Importance of Niche Provider for Successful NDA Submission: Rescue Case Study Aparna Poona, Vita Data Sciences, Waltham, MA Bhavin Busa, Vita Data Sciences, Waltham, MA Tim
More informationCDISC Production Standards Status & Plans
Bay Area User Network CDISC Production Standards Status & Plans Wayne R. Kubick Sr. Vice President, Lincoln Technologies CDISC Technical Director SDS Team Leader Agenda Topics The role and work of the
More informationUsing SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA
Paper FC04 Using SAS ETL Studio to Convert Clinical Trials Data to the CDISC SDTM Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT A new industry standard for clinical and preclinical trials
More information2016 Technical Update. August 2016
2016 Technical Update August 2016 1 Foundational Standards Key Milestones CTR ODM XML Modernize CT Process CDISC Protocol Standards IntraChange Cross-team focus Survey CTR Content Governance: Consistent
More informationAuthoring Considerations for Creating PhUSE Study Data Standardization Plan (SDSP) and CBER Appendix
Authoring Considerations for Creating PhUSE Study Data Standardization Plan (SDSP) and CBER Appendix PhUSE US Connect June 2018 Janet Low, Merck & Co., Inc., North Wales, PA, US Pritesh Solanki, Merck
More informationJanus Clinical Trials Repository: Modernizing the Review Process through Innovation
Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration Janus Clinical Trials Repository
More informationXClinical Software & Services Fast - Flexible - Focused
Fact Sheets XClinical Software & Services Fast - Flexible - Focused XClinical offers an integrated range of software products for CROs, pharmaceutical, medical device and biopharmaceutical companies. Our
More informationCDASH Clinical Data Acquisition Standards Harmonization
CDISC Italian User Group Meeting 16 November 2007 CDASH Clinical Data Acquisition Standards Harmonization 1 Outline Background Organization Goals Timelinesand Process Review of progress Results Future
More informationCDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource
CDISC/TransCelerate Collaboration and TransCelerate work streams -Clinical Data Standards -Common Protocol Template -esource July 2016 TransCelerate Clinical Data Standards Project Opportunity
More informationIndustrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence
Industrialized Clinical Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Executive Summary The majority of commercially available legacy
More informationDRIVING CLINICAL DATA STANDARDS BEYOND COMPLIANCE
SMARTER DRUG DEVELOPMENT DRIVING CLINICAL DATA STANDARDS BEYOND COMPLIANCE Binding FDA requirements take effect in 2016 will your data standards platform do more than simply comply? INTRODUCTION In December
More informationSAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China
PharmaSUG China 2015 - Paper 29 SAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China ABSTRACT Are you in trouble with executing timely queries against historical or ongoing clinical
More informationApproaches and Challenges in Implementing CDISC Standards DC DCISC User Group Meeting
Approaches and Challenges in Implementing CDISC Standards DC DCISC User Group Meeting 2007-09-13 Musa Nsereko, BDS MPH Sr. Manager, Clinical Data Programming Cephalon, Inc. Member CDISC SDS Team Co-leader
More informationEnd-to-End Management of Clinical Trials Data
End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....
More informationFDASmart Inc. EDC & CDM Solutions
FDASmart Inc. EDC & CDM Solutions Our Services Validation of EDC Products as per Client Requirement with compliance with FDA s CFR 21 Part 11 Training on EDC Rave Helps to prepare SOPs and SWIs related
More informationWelcome to the American College of Toxicology s Webinar Series. We will begin at 11AM EDT
Welcome to the American College of Toxicology s Webinar Series We will begin at 11AM EDT Preparing for Nonclinical edata Regulatory Submissions to the US FDA SEND and Beyond September 5, 2013, 11:00 AM
More informationAdvanced workflow of review/consultation
PMDA Update Yuki Ando, PhD Senior Scientist for Biostatistics Advanced Review with Electronic Data Promotion Group Pharmaceuticals and Medical Devices Agency CDISC 2016 1 Advanced workflow of review/consultation
More informationSteps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition
Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition David Izard, MS Terek Peterson, MBA Richard Addy, MS CDISC ODM SDTM LAB CDASH ADaM PRM SEND Controlled
More informationClinical Data Standards Governance. Tammy Burns, Expert Clinical Data Manager 11 th January 2013
Clinical Data Standards Governance Tammy Burns, Expert Clinical Data Manager 11 th January 2013 Standards Used and Formal Govenance Standard Types General and Therapeutic Area Data Standards Collection
More informationNEW AGILE CLINICAL TRIALS SUCH AS ADAPTIVE DESIGNS AND THE USE OF THE SAS LIFE SCIENCE ANALYTICAL FRAMEWORK
NEW AGILE CLINICAL TRIALS SUCH AS ADAPTIVE DESIGNS AND THE USE OF THE SAS LIFE SCIENCE ANALYTICAL FRAMEWORK DR. MARK LAMBRECHT, ADVISORY INDUSTRY CONSULTANT SAS HEALTH AND LIFE SCIENCES GLOBAL PRACTICE
More informationElectronic Data Submission and Utilization in Japan
PharmaSUG 2018 April 29 - May 2, Seattle, Washington Electronic Data Submission and Utilization in Japan Yuki Ando, PhD Senior Scientist for Biostatistics Office of Advanced Evaluation with Electronic
More information2010 CDISC Japan Interchange
2010 6 28 2010 CDISC Japan Interchange Japan CDISC Coordinating Committee (J3C) Chair 2010 7 20 7 23 4 7 20 21 7 22 23 102-0093 2-4-1 Tel 03-3265-8211 http://www.toshicenter.co.jp CDISC http://www.cdisc.org/interchange
More informationPreclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration
Preclinical Data Standardization Process for regulatory submission to U.S. Food and Drug Administration Gabriele Pesavento, 23 May 2018 Aptuit An Evotec company A full service CRO that delivers purpose
More informationImplementing Clinical Trial Data Standards
Bernd Doetzkies, Director Informatics Daiichi Sankyo Pharma Development PRISME Forum SIG Meeting 17Oct2011 Implementing Clinical Trial Data Standards Clinical Development Business Trends Resistance to
More informationMANAGING AND ANALYZING CLINICAL DATA MARK LAMBRECHT, PRINCIPAL INDUSTRY CONSULTANT, SAS BIAS MEETING, MARCH 14 TH 2014, MILAN, ITALY.
MANAGING AND ANALYZING CLINICAL DATA MARK LAMBRECHT, PRINCIPAL INDUSTRY CONSULTANT, SAS BIAS MEETING, MARCH 14 TH 2014, MILAN, ITALY. TABLE OF CONTENTS SAS and CDISC Clinical trial challenges The promise
More informationBreakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015
Breakout session notes CDISC UK Network Face to Face meeting June 23 rd 2015 Questions that came up during the breakout sessions are colour-coded: Blue questions that were answered during the session,
More informationADaM 2018: What s New and What s Coming. Jack Shostak, Duke Clinical Research Institute Sandra Minjoe, PRA
ADaM 2018: What s New and What s Coming Jack Shostak, Duke Clinical Research Institute Sandra Minjoe, PRA 05.22.2018 Agenda 1. Update on ADaM subteams 2. Documents summary 3. ADaM future plans Subteam
More informationCDISC Global Update. President and CEO, CDISC
CDISC Global Update Rebecca D. Kush, PhD President and CEO, CDISC CDISC Advisory Board Program Committee CherylSimon* Peter Van Reusel* Gary Walker* Marcelina Hungria Dave Handelsman* Patrick Genyn* Sharon
More informationSAS Life Science Analytics Framework
CDISC Italian User Network Day 21Oct2016 (Data standard e loro applicazione) SAS Life Science Analytics Framework STIJN ROGIERS - SAS SENIOR INDUSTRY CONSULTANT GLOBAL PRACTICE, HEALTH & LIFE SCIENCES
More informationINTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING
INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING Wim Verreth 4 th Annual Outsourcing in Clinical Trials 21-22 May 2014 OUTLINE What is Clinical Automation? Why we
More informationPhUSE Paper PP07. EPOCH in Reverse. Ann Croft, LEO Pharma, Hurley, UK
Paper PP07 EPOCH in Reverse Ann Croft, LEO Pharma, Hurley, UK ABSTRACT After supplying test data through the electronic gateway to the FDA, LEO Pharma was informed that the FDA required some updates to
More informationImplementation and Operation of CDISC ODM-based EDC by UMIN
Implementation and Operation of CDISC ODM-based EDC by UMIN Takahiro Kiuchi, M.D., Ph.D. UMIN Center, The University of Tokyo Hospital, Tokyo, Japan 1 Content 1. CDISC standards and academic research 2.
More informationCDISC Controlled Terminology: Let s Speak the Same Language
CDISC Controlled Terminology: Let s Speak the Same Language DCDISC User Network November 8, 2011 Chris Tolk Director, Terminology Agenda Overview / Objectives Key Drivers Terminology Development SDTMIG
More informationTransCelerate BioPharma, Inc. Clinical Data Standards Project. Dave Jordan Data Standards Project Leader
TransCelerate BioPharma, Inc. Clinical Data Standards Project Dave Jordan Data Standards Project Leader 1 Outline TransCelerate Overview CFAST Overview Therapeutic Area Standards Project CDISC SHARE Q
More informationCDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017
CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC 2017 1 Panelists Jim LaPointe Managing Director, Cambridge Semantics Patrick
More informationPharmaSUG 2017 Paper DS14
PharmaSUG 2017 Paper DS14 Considerations in Submitting Standardized Electronic Data Under the Animal Rule: The Use of SDTMIG and SENDIG Domains, and the Need for New Domains and Concepts Fred Wood, Accenture
More informationBIOMETRICS SERVICES ADVISORY DATA OFFICE UNBLINDING SECURE INDEPENDENT TEAM PROGRAM. ADaM TRAINER SAFETY SDTM COMPLIANT TA-EXPERTISE SDTM DATA
BIOMETRICS SERVICES DELIVER UNBLINDED DATASETS TO IDMC SDTM-IG UNBLINDING ADVISORY QUALITY ON TIME DEDICATED DATA SECURE BOARD EMERGENCY PARTNERSHIPTEAM DATA OFFICE UNBLINDING INVESTINGEXPERTISE SHARING
More informationRoadmap for Managing Multiple CRO Vendors
PharmaSUG 2017 - Paper PO27 Roadmap for Managing Multiple CRO Vendors Veena Nataraj, Shire, Lexington, MA Karin LaPann, Shire, Lexington, MA ABSTRACT When working with CROs, the relationship established
More informationThe Do's/Don'ts, An SDTM Validation Perspective. The should/shouldn't when explaining issues in the SDRG (Study Data Reviewer s Guide)
PharmaSUG 2017 - Paper SS10 The Do's/Don'ts, An SDTM Validation Perspective. The should/shouldn't when explaining issues in the SDRG (Study Data Reviewer s Guide) Tom Guinter, Independent Consultant, Data
More informationThe use of electronic Health Records in Clinical Research - The value of CDISC Standards
The use of electronic Health Records in Clinical Research - The value of CDISC Standards FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria Who is Jozef Aerts? CDISC volunteer
More informationHarnessing the power of clinical data
Harnessing the power of clinical data Harnessing the power of clinical data Managing the data burden Life sciences companies are rich in data and gaining exponentially more clinical data all the time.
More informationCDISC Journal. Genzyme s GetSMART Program: Implementing Standards End-to-End
CDISC Journal Clinical Data Interchange Standards Consortium O ctober 2011 Genzyme s GetSMART Program: Implementing Standards End-to-End By Sue Dubman, Brooke Hinkson, Dana Soloff, David Fritsche and PK
More informationCDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008
CDISC Controlled Terminology across the Clinical Trial Continuum Bay Area Implementation Network 6 March 2008 Bron Kisler Co-Founder / Director of Terminology CDISC Terminology Initiative Overview / Background
More informationREQUEST FOR PROPOSAL. Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide. October 2018
REQUEST FOR PROPOSAL Statistical Programing Expert Crohn s Disease Therapeutic Area User Guide - SPONSOR: CDISC October 2018 1 Contents Executive Summary... 3 Project Description... 3 Task Description...
More informationCDISC Journal. Current status and future scope of CDISC standards. By Rebecca D. Kush, President and CEO, CDISC. 1. Introduction
CDISC Journal Clinical Data Interchange Standards Consortium oc tober 2012 Current status and future scope of CDISC standards By Rebecca D. Kush, President and CEO, CDISC 1. Introduction In translational
More informationOptimizing Your Study Data Submissions to FDA Updates from CDER and CBER
This single PDF file contains the slides for all three presentations in the webinar: Optimizing Your Study Data Submissions to FDA Updates from CDER and CBER Please page down to find the slides for all
More informationEileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA
Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA 1 www.fda.gov WHAT MEDICAL REVIEWERS CAN DO WITH STANDARDIZED DATA AND METADATA RECEIVED IN MODULE 5 Eileen Navarro, MD, FACP OCS/OTS/CDER/FDA
More informationPutting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay
How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC Mark Vieder,
More informationCDISC Standards: Summary
Business Case for CDISC Standards: Summary PhRMA-Gartner-CDISC Project September 2006 Carol Rozwell, Gartner Rebecca Daniels Kush, CDISC Ed Helton, SAS Frank Newby, CDISC Tanyss Mason, CDISC Clinical Data
More informationData standardization and advancing regulatory science
Data standardization and advancing regulatory science Yoshiaki Uyama, Ph.D. Pharmaceuticals & Medical Devices Agency (PMDA) Visiting Professor, Graduate School of Medicine, Chiba University Visiting Professor,
More informationBiomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape
Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape Introduction Biomarkers and specialty labs are core to modern clinical trials.the broad and evergrowing
More informationSAS & Clinical Data Repository Karthikeyan Chidambaram
SAS & Clinical Data Repository Karthikeyan Chidambaram Cognizant Technology Solutions, Newbury Park, CA Clinical Data Repository (CDR) Drug development lifecycle consumes a lot of time, money and effort.
More informationMeeting Minutes. CDISC-HL7 Stage I-B January 14-15, :00 am 12:30 pm (EST) HL7 Orlando, FL
Meeting Minutes CDISC-HL7 Stage I-B January 14-15, 2009 9:00 am 12:30 pm (EST) HL7 Orlando, FL Attendees / Affiliation ATTENDEES COMPANY 1/14 Q1 1/14 Q2 1/15 Q1 1/15 Q2 Jay Levine FDA X X X X (co-chair)
More informationThe Anatomy of Clinical Trials Data: A Beginner s Guide
ABSTRACT Paper 1759-2018 The Anatomy of Clinical Trials Data: A Beginner s Guide Venky Chakravarthy, BioPharma Data Services, Ann Arbor, Michigan An audience that wants to learn more about clinical trials
More informationQuestion and Answer Guide Regarding Notification on Practical Operations of Electronic Study Data Submissions
Administrative Notice April 27, 2015 To: Prefectrual Health Department (Bureau) Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Question
More informationAepodia is a team of experts with more than 15 years
Aepodia is a team of experts with more than 15 years experience in early clinical development and translational science with small startup and large global pharmaceutical companies. Aepodia s team has
More information9th Annual SAS Health Care & Life Sciences Executive Conference
: An Integrated Platform to Promote Data Exchange, Collaboration, and Advanced Analytics 9th Annual SAS Health Care & Life Sciences Executive Conference 9-10 May 2012 Bernd Doetzkies, Director Informatics
More informationExploration des données d essais cliniques en utilisant le standard CDISC
Exploration des données d essais cliniques en utilisant le standard CDISC Florence Kussener French System Engineer Florence.Kussener@jmp.com SAS Institute AGENDA Outcomes of using CDISC standards Case
More informationCDASH 2.0. Berlin Éanna Kiely CDISC Engineer
CDASH 2.0 Berlin Éanna Kiely CDISC Engineer 2016-09-13 Agenda CDASH 1.1 & CDASHIG 2.0 CDASH Concepts TAUG Examples Current Regulatory Perspective on CDASH Questions 2 CDASH: CDISC End to End Clinical Data
More informationElectronic Data Submission and Utilization in Japan
PharmaSUG SDE Japan 2018 Electronic Data Submission and Utilization in Japan Hiromi Sugano Biostatistics Reviewer Office of New Drug II / Office of Advanced Evaluation with Electronic Data Pharmaceuticals
More informationCDISC Journal. Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit
CDISC Journal Clinical Data Interchange Standards Consortium oc tober 2012 Organizing and Accelerating the Clinical Research Process from the Beginning: The CDISC Protocol Representation Model and Toolkit
More informationCDISC Controlled Terminology: Let s Speak the Same Language. CDISC User Group Meeting March 12, 2009
CDISC Controlled Terminology: Let s Speak the Same Language CDISC User Group Meeting March 12, 2009 Agenda Key Terminology Objectives Key Drivers Terminology Production and Development Future Plans 2 Terminology
More informationXClinical Software & Services
Fact Sheets XClinical Software & Services XClinical was founded in Munich (Germany) in 2002 with a vision to build a new EDC system leveraging CDISC standards to accelerate the database build and reduce
More informationElectronic Health Records and Clinical Data Interchange Standards. Stephen E. Wilson, Dr.P.H., CAPT USPHS. Director. Division of Biostatistics III
Electronic Health Records and Clinical Data Interchange Standards Stephen E. Wilson, Dr.P.H., CAPT USPHS Director Division of Biostatistics III Center for Drug Evaluation and Research US Food and Drug
More informationCross functional standards governance for pharma
Paper DS08/PP17 Cross functional standards governance for pharma Warwick Benger, GlaxoSmithKline, UK Sheetal Patel, GlaxoSmithKline, UK ABSTRACT The regulatory and standards environment for clinical research
More informationClinical Data in Business Intelligence
Paper DV07 Clinical Data in Business Intelligence Mike Collinson, Oracle Heath Sciences Consulting (HSC), Reading, UK ABSTRACT Clinical organizations are under increasing pressure to execute clinical trials
More informationMANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners
MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical
More informationDisease Specific Data Standards: Case Studies in TB and Cardiology
CDISC 2010 Disease Specific Data Standards: Case Studies in TB and Cardiology CDISC Japan Interchange 20 July 2010 Bron Kisler bkisler@cdisc.org CDISC 2010 Presentation Outline Why disease-specific standards?
More informationambiguous insights through HCL s R&D Transformation limit your business
ambiguous insights through HCL s R&D Transformation limit your business Life Sciences industry is undergoing a transformational change - blockbuster patent expirations, global interconnected world, and
More informationElectronic Health Records and Clinical Data Interchange Standards
Electronic Health Records and Clinical Data Interchange Standards Stephen E. Wilson, Dr.P.H., CAPT USPHS Director Division of Biostatistics III Center for Drug Evaluation and Research US Food and Drug
More informationClinical Data Acquisition Standards Harmonization (CDASH)
Clinical Data Acquisition Standards Harmonization () Prepared by: CDISC Team Section Table of Contents Page 1.0 Orientation... 1 1.1 Purpose... 1 1.2 Organization of this Document... 1 1.2.1 General Notes...2
More informationDisclaimers The views expressed are those of the presenter and not necessarily of the FDA With the FDA, as with the stock market, past performance is
Managing Biometrics Tasks for an ectd Submission 1 Disclaimers The views expressed are those of the presenter and not necessarily of the FDA With the FDA, as with the stock market, past performance is
More informationTrial Summary: The Golden Gate towards a Successful Submission
PharmaSUG 2018 - Paper SS-04 Trial Summary: The Golden Gate towards a Successful Submission ABSTRACT Bhargav Koduru, and Girish Kankipati, Seattle Genetics Inc. Trial Summary (TS) has gained importance
More informationLIFE SCIENCE ANALYTICS FRAMEWORK (LSAF)
PaperTT-15 Incorporating Pinnacle21 With LSAF Sonali Garg, Alexion Pharmaceuticals, New Haven, USA Sandeep Juneja, SAS Institute, Cary, USA Aleksey Vinokurov, Pinnacle21, Plymouth Meeting, USA ABSTRACT
More informationInvestigator-Initiated INDs
Investigator-Initiated INDs Marjorie Small, RN, CCRC Office of Clinical Research 23 May 2011 PPHS/IRB Research Grand Rounds Outline of Presentation I. What is an IND? II. Code of Federal Regulations III.
More informationPharmaSUG Paper PO12
PharmaSUG 2016 - Paper PO12 CDISC Standards End-to-End: Transitional Hurdles Alyssa Wittle, Chiltern International, King of Prussia, PA Christine McNichol, Chiltern International, King of Prussia, PA Antonio
More informationControlled Terminology
CDISC Italian User Group 16 November 2007 Controlled Terminology Cecilia Moresino Helsinn Healthcare Controlled Terminology A finite set of values that represent the only allowed values for a data item.
More informationStandard for Exchange of Nonclinical Data Implementation Guide: Nonclinical Studies
Standard for Exchange of Nonclinical Data Implementation Guide: Nonclinical Studies Prepared by the CDISC Standard for Exchange of Nonclinical Data Team Notes to Readers This is the implementation guide
More informationBIOCLINICA CLINICAL DATA MANAGEMENT
BIOCLINICA CLINICAL DATA MANAGEMENT Achieve faster speed to market, with Bioclinica s best-in-class Electronic Data Capture (EDC) technology and in-house full-service Data Management (DM) services. $ BIOCLINICA
More informationNice SUPPQUAL Variables to Have Beilei Xu, Merck & Co., Inc., Rahway, NJ Changhong Shi, Merck & Co., Inc., Rahway, NJ
Paper RS05 Nice SUPPQUAL Variables to Have Beilei Xu, Merck & Co., Inc., Rahway, NJ Changhong Shi, Merck & Co., Inc., Rahway, NJ ABSTRACT A Supplemental Qualifier (SUPPQUAL) data set is a special Study
More informationUse and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results
Use and Evaluation of Standards for Investigator-Initiated Studies: Preliminary Results M. Theresa Perry RTRN (DTCC) 2010 AMIA Summit on Clinical Research Informatics March 12-13, 2010 Parc 55 Hotel San
More informationWork with me here...(or there or anywhere): Practical Cloud Collaboration with JMP Clinical for Clinical Trial Data Reviews
PharmaSUG 2017 - Paper AD07 Work with me here...(or there or anywhere): Practical Cloud Collaboration with JMP Clinical for Clinical Trial Data Reviews ABSTRACT Kelci Miclaus and Drew Foglia, SAS Institute
More informationPaper MA04. Greg Nelson ThotWave Technologies, Cary, North Carolina
Paper MA04 Using SAS 9 in Clinical Research Greg Nelson ThotWave Technologies, Cary, North Carolina Abstract For 30 years SAS has been used in pharmaceutical research settings for data management, analytics
More informationSpecific pathologist responses for Standard for Exchange of Nonclinical Data (SEND)
J Toxicol Pathol 2017; 30: 201 207 Review Specific pathologist responses for Standard for Exchange of Nonclinical Data (SEND) Atsushi Watanabe 1, 2*, Osamu Kusuoka 1, Norihiro Sato 1, Osamu Nakazono 1,
More information